CY1119402T1 - Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες - Google Patents
Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντεςInfo
- Publication number
- CY1119402T1 CY1119402T1 CY20171100071T CY171100071T CY1119402T1 CY 1119402 T1 CY1119402 T1 CY 1119402T1 CY 20171100071 T CY20171100071 T CY 20171100071T CY 171100071 T CY171100071 T CY 171100071T CY 1119402 T1 CY1119402 T1 CY 1119402T1
- Authority
- CY
- Cyprus
- Prior art keywords
- antibacterial agents
- kinolin
- products
- compound
- bacterial infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
Abstract
Χρήση μίας ένωσης για την παρασκευή ενός φαρμάκου για τη θεραπευτική αντιμετώπιση μιας βακτηριακής λοίμωξης με την προϋπόθεση ότι η βακτηριακή λοίμωξη είναι διαφορετική από μία Μυκοβακτηριακή λοίμωξη, με την εν λόγω ένωση να είναι μία ένωση του τύπου (Ia) ή (lb) ένα N-οξείδιο, μία ταυτομερή μορφή ή μία στερεοχημικώς ισομερή μορφή αυτής. Οι ίδιες οι ενώσεις αξιώνονται επίσης καθώς και οι συνδυασμοί τους με άλλους αντιβακτηριακούς παράγοντες.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05105755 | 2005-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1119402T1 true CY1119402T1 (el) | 2018-03-07 |
Family
ID=35447198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20171100071T CY1119402T1 (el) | 2005-06-28 | 2017-01-18 | Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US20130030016A1 (el) |
| EP (1) | EP1898909B1 (el) |
| JP (1) | JP5193857B2 (el) |
| KR (1) | KR101329587B1 (el) |
| CN (1) | CN101252927B (el) |
| AP (1) | AP2547A (el) |
| AR (1) | AR054804A1 (el) |
| AU (1) | AU2006263882B2 (el) |
| BR (1) | BRPI0613999B8 (el) |
| CA (1) | CA2612614C (el) |
| CY (1) | CY1119402T1 (el) |
| DK (1) | DK1898909T3 (el) |
| EA (1) | EA014431B1 (el) |
| ES (1) | ES2610472T3 (el) |
| HK (1) | HK1120732A1 (el) |
| HR (1) | HRP20170044T1 (el) |
| HU (1) | HUE030264T2 (el) |
| IL (1) | IL188395A (el) |
| JO (1) | JO3322B1 (el) |
| LT (1) | LT1898909T (el) |
| MX (1) | MX2008000079A (el) |
| MY (1) | MY173664A (el) |
| NO (1) | NO341285B1 (el) |
| NZ (1) | NZ564340A (el) |
| PL (1) | PL1898909T3 (el) |
| PT (1) | PT1898909T (el) |
| RS (1) | RS55601B1 (el) |
| SG (1) | SG166798A1 (el) |
| TW (1) | TWI413520B (el) |
| UA (1) | UA88701C2 (el) |
| WO (1) | WO2007000434A1 (el) |
| ZA (1) | ZA200711148B (el) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2752B1 (en) | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
| JO2970B1 (en) | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JP5397881B2 (ja) * | 2008-09-04 | 2014-01-22 | 昇一 城武 | グラム陽性細菌用抗菌剤及び抗菌活性増強剤 |
| DK2841426T3 (en) | 2012-04-27 | 2017-01-09 | Janssen Pharmaceutica Nv | ANTIBACTERIAL QUINOLIN DERIVATIVES |
| EP2841425B1 (en) | 2012-04-27 | 2016-03-23 | Janssen Pharmaceutica, N.V. | Antibacterial quinoline derivatives |
| JP7514763B2 (ja) * | 2017-10-13 | 2024-07-11 | ザ ユニバーシティー オブ クイーンズランド | 亜鉛イオノフォアおよびその使用 |
| CN110606825A (zh) * | 2019-10-30 | 2019-12-24 | 成都海杰亚医药科技有限公司 | 一种制备吡啶-2-硫醇的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| PL222801B1 (pl) * | 2002-07-25 | 2016-09-30 | Janssen Pharmaceutica Nv | Pochodne chinoliny, ich zastosowanie, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca je |
| UA90267C2 (ru) * | 2004-05-28 | 2010-04-26 | Янссен Фармацевтика Н.В. | Применение замещенных хинолиновых производных для лечения заболеваний, вызванных микобактериями, резистентными к лекарственным средствам |
| EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
| EE05697B1 (et) * | 2005-06-08 | 2014-02-17 | Janssen Pharmaceutica N.V. | Kinoliini derivaadid kui antibakteriaalsed toimeained |
-
2006
- 2006-06-26 ES ES06763888.2T patent/ES2610472T3/es active Active
- 2006-06-26 PL PL06763888T patent/PL1898909T3/pl unknown
- 2006-06-26 AU AU2006263882A patent/AU2006263882B2/en active Active
- 2006-06-26 MY MYPI20063021A patent/MY173664A/en unknown
- 2006-06-26 NZ NZ564340A patent/NZ564340A/en unknown
- 2006-06-26 UA UAA200714928A patent/UA88701C2/ru unknown
- 2006-06-26 SG SG201007976-2A patent/SG166798A1/en unknown
- 2006-06-26 KR KR1020087002246A patent/KR101329587B1/ko active IP Right Grant
- 2006-06-26 PT PT67638882T patent/PT1898909T/pt unknown
- 2006-06-26 JP JP2008518809A patent/JP5193857B2/ja not_active Expired - Fee Related
- 2006-06-26 EA EA200800151A patent/EA014431B1/ru unknown
- 2006-06-26 WO PCT/EP2006/063552 patent/WO2007000434A1/en active Application Filing
- 2006-06-26 BR BRPI0613999A patent/BRPI0613999B8/pt not_active IP Right Cessation
- 2006-06-26 EP EP06763888.2A patent/EP1898909B1/en active Active
- 2006-06-26 HU HUE06763888A patent/HUE030264T2/en unknown
- 2006-06-26 CA CA2612614A patent/CA2612614C/en active Active
- 2006-06-26 CN CN200680031302.9A patent/CN101252927B/zh active Active
- 2006-06-26 LT LTEP06763888.2T patent/LT1898909T/lt unknown
- 2006-06-26 MX MX2008000079A patent/MX2008000079A/es active IP Right Grant
- 2006-06-26 RS RS20170045A patent/RS55601B1/sr unknown
- 2006-06-26 DK DK06763888.2T patent/DK1898909T3/en active
- 2006-06-26 AP AP2008004298A patent/AP2547A/xx active
- 2006-06-27 AR ARP060102758A patent/AR054804A1/es unknown
- 2006-06-27 TW TW095123049A patent/TWI413520B/zh not_active IP Right Cessation
- 2006-06-29 JO JOP/2006/0183A patent/JO3322B1/ar active
-
2007
- 2007-12-20 ZA ZA2007/11148A patent/ZA200711148B/en unknown
- 2007-12-25 IL IL188395A patent/IL188395A/en active IP Right Grant
-
2008
- 2008-01-28 NO NO20080499A patent/NO341285B1/no not_active IP Right Cessation
- 2008-11-17 HK HK08112566.1A patent/HK1120732A1/xx unknown
-
2012
- 2012-08-07 US US13/568,569 patent/US20130030016A1/en not_active Abandoned
-
2017
- 2017-01-11 HR HRP20170044TT patent/HRP20170044T1/hr unknown
- 2017-01-18 CY CY20171100071T patent/CY1119402T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1119402T1 (el) | Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες | |
| CY1120081T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
| CY1117766T1 (el) | Αντιβακτηριδιακα παραγωγα κινολινης | |
| CY1123705T1 (el) | Αλατα και πολυμορφα μιας ενωσης τετρακυκλινης | |
| CY1124173T1 (el) | Υποκατεστημενες ενωσεις αμινοπουρινης, συνθεσεις αυτων και μεθοδοι θεραπειας με αυτες | |
| CY1124086T1 (el) | Παραγωγα 3-τετραζολυλ-βενζεν-1,2-δισουλφοναμιδιου ως αναστολεις μεταλλο-βητα-λακταμασης | |
| CY1119361T1 (el) | 3,4-διυδροισοκινολιν-2(1h)-υλικες ενωσεις | |
| CY1120269T1 (el) | Ετεροδικυκλικες ενωσεις ως αναστολεις βητα-λακταμασης | |
| CY1118515T1 (el) | Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες | |
| CY1109644T1 (el) | 2,4-διαμινο-πυριμιδινες ως αναστολεις audora | |
| CY1118993T1 (el) | Υποκατεστημενες ενωσεις τετραϋδροϊσοκινολινης ως αναστολεις τελεστη xiα | |
| CY1118650T1 (el) | Παραγωγα βενζιμιδαζολιου | |
| CY1110127T1 (el) | Υποκατεστημενες 1-προπιολυλο-πιπεραζινες με χημικη συγγενεια για τον υποδοχεα mglur5 για τη θεραπεια καταστασεων πονου | |
| CY1114277T1 (el) | ΕΝΩΣΕΙΣ ΙΜΙΔΑΖΟ[1,2-a]ΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΑΣΤΟΛΕΙΣ ΥΠΟΔΟΧΕΑ ΚΙΝΑΣΗΣ ΤΥΡΟΣΙΝΗΣ | |
| CY1112151T1 (el) | Αγωνιστες τυπου πυριδονης του συζευγμενου με g-πρωτεϊνη υποδοχεα gpr119 | |
| CY1114318T1 (el) | Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες | |
| BRPI0716598A2 (pt) | Derivados de (hetero) arilsulfonamida de n-biarila úteis no tratamento de doenças medidas por interações de linfócitos | |
| CR9113A (es) | Compuestos acetamida como fungicidas | |
| UY31940A (es) | Derivados sustituido del 4,5-(sustituido-piridin-3-il)-1-metil-1h-indol, sus sales farmacéuticamente aceptables, polimorfos, rotámeros, pro-fármacos, anantiómeros, hidratos, solvatos del mismo, composiciones conteniéndolos y aplicaciones | |
| ECSP10010014A (es) | Derivados de 2-alquiltio-2-quinoliniloxi-acetamida como fungicidas | |
| CY1113352T1 (el) | Ενωση σπειρο-δακτυλιου και χρηση αυτης για ιατρικους σκοπους | |
| CY1111830T1 (el) | Παραγωγα πυριδινης ως ρυθμιστες υποδοχεων s1p1/edg1 | |
| CY1113244T1 (el) | Ενωση ουρακιλης η οποια εχει ανασταλτικη δραστικοτητα σε ανθρωπινη τριφωσφαταση δεοξυουριδινης ή αλας αυτης | |
| CY1121885T1 (el) | Αντι-ογκικες ενωσεις | |
| BR112018073619A2 (pt) | derivados de oxadiazol microbiocidas |